kras mutation and glutathion BRAFV600E in colorectal cancer reduces sensitivity to oxidative stress promotes site-specific metastasis by stimulating glutathione synthesis: Cell Reports KRAS-targeted therapies in cancer: novel
KRAS targeted therapies in cancer: novel approaches and overcoming resistance BMJ Oncology Targeting KRAS: from metabolic regulation to cancer treatment Molecular Cancer Springer Nature Link The KRAS G12D mutation induces metabolic vulnerability in B cell acute lymphoblastic leukemia ScienceDirect Uncovering new therapeutic targets for a common KRAS mutation behind cancer
Pay in 4 interest-free payments of $6.60 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



